9-137175369-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_013366.4(ANAPC2):c.2124G>T(p.Glu708Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000844 in 1,611,438 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013366.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANAPC2 | NM_013366.4 | c.2124G>T | p.Glu708Asp | missense_variant | 12/13 | ENST00000323927.3 | NP_037498.1 | |
LOC124902315 | XR_007061879.1 | n.773C>A | non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANAPC2 | ENST00000323927.3 | c.2124G>T | p.Glu708Asp | missense_variant | 12/13 | 1 | NM_013366.4 | ENSP00000314004 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152242Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000152 AC: 37AN: 244146Hom.: 0 AF XY: 0.000113 AC XY: 15AN XY: 133010
GnomAD4 exome AF: 0.0000459 AC: 67AN: 1459078Hom.: 1 Cov.: 34 AF XY: 0.0000386 AC XY: 28AN XY: 725758
GnomAD4 genome AF: 0.000453 AC: 69AN: 152360Hom.: 0 Cov.: 34 AF XY: 0.000443 AC XY: 33AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 08, 2024 | The c.2124G>T (p.E708D) alteration is located in exon 12 (coding exon 12) of the ANAPC2 gene. This alteration results from a G to T substitution at nucleotide position 2124, causing the glutamic acid (E) at amino acid position 708 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at